C2 p.Glu433Gly
c.1298A>G · VCV3906892
Computational evidence
| Protein change | ||
| AlphaMissense | 0.6764 | likely pathogenic |
|---|---|---|
| REVEL | 0.805 | moderately pathogenic-leaning |
| SaProt | LLR -7.69 | tolerated |
| ⇒ AlphaMissense and REVEL call this damaging; SaProt does not. | ||
| Splicing | ||
| SpliceAI | — | not looked up on this page · why |
| Constraint at this position | ||
| Conservation | phyloP 9.4 | GERP 1.8, phastCons 1 |
| Regional constraint | o/e 0.84 | unconstrained · MANE · 18 kb · p 1.1e-06 · regional, not allelic |
| Overall | ||
| CADD | 28.4 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
Absent from gnomAD v4.1. Not observed in any sequenced alleles — a rarity signal (ACMG PM2-supporting), not evidence of pathogenicity on its own.
Variant & gene context
- Gene
- C2
- Protein
- p.Glu433Gly
- Coding
- c.1298A>G
- Type
- single nucleotide variant
- Location
- chr6:31943037 (GRCh38)
Disease context
complement component 2 deficiency — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Immunodeficiency due to a classical component pathway complement deficiency (Orphanet):
- Inheritance
- Autosomal recessive
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/c2-p-glu433gly (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown